NCT03354533View on ClinicalTrials.gov

Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

November 1, 2018

Study Completion Date

November 1, 2018

Conditions

Leukocyte Adhesion Deficiency, Type II

Interventions

DRUG

L-fucose

Oral ORL-1F

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Orpha Labs

INDUSTRY

NCT03354533 - Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II | Biotech Hunter | Biotech Hunter